Retatrutide (10mg)
Retatrutide (Triple Agonist)
Triple agonist investigated for weight management and metabolic regulation in test subjects. Studies examine glucose control and energy expenditure.
Purity
≥99% (HPLC verified)
Quality
CoA Included
Form
Lyophilised Powder
Shipping
Free over $400
Overview
Retatrutide is a novel triple agonist peptide that activates GIP, GLP-1, and glucagon receptors simultaneously. Developed as a next-generation metabolic therapy, it represents cutting-edge research in weight management and metabolic disease. This multi-receptor approach provides comprehensive metabolic effects beyond single or dual agonists.
Mechanism of Action
- •Triple receptor agonist: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors
- •Enhances insulin secretion in glucose-dependent manner
- •Suppresses appetite through central nervous system pathways
- •Increases energy expenditure via glucagon receptor activation
- •Slows gastric emptying for prolonged satiety
- •Improves insulin sensitivity and glucose metabolism
- •Promotes fat oxidation and thermogenesis
Research Applications
- •Obesity and weight management research
- •Type 2 diabetes investigations
- •Metabolic syndrome studies
- •Cardiovascular health research
- •Non-alcoholic fatty liver disease (NAFLD)
- •Energy metabolism investigations
- •Appetite regulation research
Key Research Findings
- •Clinical trials show up to 24% body weight reduction
- •Research demonstrates superior weight loss compared to dual agonists
- •Studies show significant improvements in metabolic parameters
- •May provide cardiovascular benefits beyond weight loss
- •Represents next-generation approach to metabolic therapy
Dosage Guidelines
Research protocols vary widely, typically starting at low doses (2-4 mg) and titrating up to 8-12 mg administered subcutaneously once weekly. Gradual dose escalation recommended. Reconstitute with bacteriostatic water. For research purposes only.
Storage Instructions
Store lyophilized powder at 2-8°C (refrigerated). Once reconstituted, store at 2-8°C and use within 30 days. Protect from light.
For Research Purposes Only
This product is intended for laboratory research use only. Not for human consumption or clinical use. All research should be conducted in accordance with institutional guidelines and regulations. Peak Peptides Australia provides products exclusively for legitimate scientific research.
